HAVCR1 and chronic kidney disease: In recent years other biomarkers like β-trace protein (BTP), neutrophilgelatinase-associated lipoprotein (NGAL) or kidney injury molecule-1 (KIM-1) havebeen discovered as markers for CKD progression but are not yet ready to be widelyused in clinical practice and need further investigation [17].